Company Overview:
Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is searching for a dynamic Co-op to join our growing Patient Supply team within Clinical Development from January to June 2025. The Co-op, Patient Supply will support the planning and execution of clinical supply activities to support the Beam Therapeutics in-vivo and ex-vivo gene editing clinical program. This candidate’s Co-op experience will consist of a rotation with two patient supply teams: the ex-vivo patient supply team to learn and assist in activities required to provide transformational medicines for autologous therapies and with the in-vivo patient supply team to learn and assist in activities required for next-gen global therapies to ensure the right drug, to the right patient and the right time. This position will have the opportunity to interface with Clinical Operations, Quality, CMC, Regulatory, CDMOs and CROs to ensure clinical/investigational material is available as required to achieve clinical trial strategy and program timelines.
Responsibilities:
Qualifications: